Scotland Launches New ‘Ultra-Orphan’ Assessment Pathway

 
• By Ian Schofield

The Scottish government is launching its new pathway for the assessment of “ultra-orphan” medicines by the HTA body, the Scottish Medicines Consortium, in an effort to speed up access to medicines for patients with very rare diseases

Fast Track
Scotland is introducing a faster HTA process for ultra-orphan drugs.

More from Health Technology Assessment

More from Market Access